Empagliflozin prevents cardiomyopathy via sGC-cGMP-PKG pathway in type 2 diabetes mice.
- Published in:
- Clinical Science, 2019, v. 133, n. 15, p. 1705, doi. 10.1042/CS20190585
- By:
- Publication type:
- Article
Works matching IS 01435221 AND DT 2019 AND VI 133 AND IP 15
Results: 4
1
2
Mitochondrial ROS-induced lysosomal dysfunction impairs autophagic flux and contributes to M1 macrophage polarization in a diabetic condition.
- Published in:
- Clinical Science, 2019, v. 133, n. 15, p. 1759, doi. 10.1042/CS20190672
- By:
- Publication type:
- Article
3
Effect of mycophenolate and rapamycin on renal fibrosis in lupus nephritis.
- Published in:
- Clinical Science, 2019, v. 133, n. 15, p. 1721, doi. 10.1042/CS20190536
- By:
- Publication type:
- Article
4
Fatty acid oxidation inhibitor etomoxir suppresses tumor progression and induces cell cycle arrest via PPARγ-mediated pathway in bladder cancer.
- Published in:
- Clinical Science, 2019, v. 133, n. 15, p. 1745, doi. 10.1042/CS20190587
- By:
- Publication type:
- Article